Impact of Microvolt T-wave Alternans on Malignant Arrhythmia Occurrence and Mortality in Patients with Congestive Heart Failure: Single-Centre Study

ORIGINAL RESEARCH, August 2012, VOL II ISSUE II, ISSN 2042-4884
10.5083/ejcm.20424884.82 , Cite or Link Using DOI
Creating a Digital Object Identifier Link

A digital object identifier (DOI) can be used to cite and link to electronic documents. A DOI is guaranteed never to change, so you can use it to link permanently to electronic documents.

To find a document using a DOI

  1. Copy the DOI of the document you want to open.
    The correct format for citing a DOI is as follows: doi:10.1016/S0140-6736(08)61345-8
  2. Open the following DOI site in your browser:
    dx.doi.org
  3. Enter the entire DOI citation in the text box provided, and then click Go.
    The document that matches the DOI citation will display in your browser window.

The DOI scheme is administered by the International DOI Foundation. Many of the world's leading publishers have come together to build a DOI-based document linking scheme known as CrossRef.

Lubomír Křivan MD PhD, Bronislav Čapek - Student of Medicine, Petr Lokaj MD PHD, Milan Kozák MD PhD, Milan Sepši MD PhD, Lucie Burešová MSc, Jitka Vlašínová MD PhD, Jindřich Špinar MD PhD

ABSTRACT

Objectives: The aim of this study was to assess the relation between microvolt T-wave alternans (MTWA) with malignant arrhythmia occurrence and mortality in patients with ventricular systolic function < 40% due to ischemic (CAD) or nonischemic cardiomyopathy (DCMP).

Background: The predictive value of T-wave alternans for malignant arrhythmias in patients with congestive heart failure (CHF) is controversial.

Methods: In a single-centre, prospective, observational study—including patients with CHF of ischemic and nonischemic aetiology—we assessed the prognostic value of MTWA for malignant arrhythmias and total mortality.

Results: This study included 155 patients; aetiology of CHF was CAD in 67.7%, and DCMP in 32.3%. Mean left ventricular ejection fraction (LVEF) was 29%. MTWA results were 38.1% positive, 40.6% negative, and 19.4% indeterminate. Over the median follow-up of 33.8 months, 13 deaths (7 cardiac and 6 noncardiac) were observed. The death rate in MTWA-negative patients did not significantly differ from that in MTWA-non negative patients (p = 0.203). There was also no difference in death rate between CAD and DCMP patients (p = 0.211). In only CAD patients, nonnegative MTWA predicted significantly higher occurrence of malignant arrhythmias (p = 0.033). This correlation was not significant for the total group (p = 0.100), or for the DCMP subgroup (p = 1.000).

Conclusions: The negative predictive value of MTWA for malignant arrhythmias was 79.4%. Significant reduction of malignant arrhythmias in MTWA-negative patients was valid only in the CAD subgroup. The impact of MTWA on mortality was not significant.